Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Dexamethasone for Brain Metastases
NCT00188864Phase 2Completed
- Sponsor
- University Health Network
- Start
- Nov 2003
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of dexamethasone in brain metastases (2 arms), sponsored by University Health Network. Primary endpoint: Statistical evaluation of patients regarding the role of steroid therapy in managing patients with cerebral metastases. Started Nov 2003; status: completed.
02
Drugs
dexamethasone
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00188864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00188864.